- Home
- DRIO vs ANTX Comparison
DRIO vs ANTX Comparison
Compare DRIO & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- ANTX
- Stock Information
- Founded
- DRIO 2011
- ANTX 2017
- Country
- DRIO United States
- ANTX United States
- Employees
- DRIO N/A
- ANTX N/A
- Industry
- DRIO Medical/Dental Instruments
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- DRIO Health Care
- ANTX Health Care
- Exchange
- DRIO Nasdaq
- ANTX Nasdaq
- Market Cap
- DRIO 30.5M
- ANTX 33.2M
- IPO Year
- DRIO N/A
- ANTX 2022
- Fundamental
- Price
- DRIO $0.72
- ANTX $1.07
- Analyst Decision
- DRIO Strong Buy
- ANTX Buy
- Analyst Count
- DRIO 2
- ANTX 2
- Target Price
- DRIO $2.50
- ANTX $2.00
- AVG Volume (30 Days)
- DRIO 119.0K
- ANTX 289.9K
- Earning Date
- DRIO 08-07-2025
- ANTX 08-12-2025
- Dividend Yield
- DRIO N/A
- ANTX N/A
- EPS Growth
- DRIO N/A
- ANTX N/A
- EPS
- DRIO N/A
- ANTX N/A
- Revenue
- DRIO $28,034,000.00
- ANTX N/A
- Revenue This Year
- DRIO $13.66
- ANTX N/A
- Revenue Next Year
- DRIO $24.50
- ANTX N/A
- P/E Ratio
- DRIO N/A
- ANTX N/A
- Revenue Growth
- DRIO 47.20
- ANTX N/A
- 52 Week Low
- DRIO $0.50
- ANTX $0.87
- 52 Week High
- DRIO $1.55
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- DRIO 54.45
- ANTX 45.19
- Support Level
- DRIO $0.69
- ANTX $1.07
- Resistance Level
- DRIO $0.73
- ANTX $1.11
- Average True Range (ATR)
- DRIO 0.03
- ANTX 0.04
- MACD
- DRIO 0.00
- ANTX 0.00
- Stochastic Oscillator
- DRIO 68.03
- ANTX 28.57
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.